Evaluation of Two Zika Viruses for Use in Controlled Human Infection Models (CHIM)

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

February 16, 2022

Primary Completion Date

September 3, 2024

Study Completion Date

September 3, 2024

Conditions
Zika Virus
Interventions
BIOLOGICAL

ZIKV-SJRP/2016-184 Strain

Zika Virus Strain (San Jose Rio Puerto)

BIOLOGICAL

Experimental: ZIKV-Nicaragua/2016 Strain

Zika Virus Strain (Nicaragua)

BIOLOGICAL

Placebo

Saline

Trial Locations (1)

21202

Johns Hopkins University, Bloomberg School of Public Health, Baltimore

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH